Search results
STADA and Alvotech launch Uzpruvo biosimilar in Europe By Investing.com
Investing.com· 4 days agoThe release of Uzpruvo® follows the expiration of exclusivity rights for the reference molecule,...
Zacks Research Brokers Decrease Earnings Estimates for AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at Zacks Research dropped their Q4 2024 earnings per share (EPS) estimates for shares of AbbVie in a report issued on Tuesday, July ...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
Zacks· 19 hours agoAstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.
Q3 2024 EPS Estimates for Amgen Inc. (NASDAQ:AMGN) Raised by Analyst
ETF DAILY NEWS· 2 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Investment analysts at William Blair increased their Q3 2024 earnings estimates for shares of Amgen in a note issued to investors on Tuesday, July 23rd ...
State Board of Administration of Florida Retirement System Has $1.09 Million Position in Option Care...
ETF DAILY NEWS· 14 hours agoState Board of Administration of Florida Retirement System reduced its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 29.7% during the 1st quarter, according to ...
AbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $2.56 Per Share, Zacks Research Forecasts
ETF DAILY NEWS· 22 hours agoAbbVie Inc. (NYSE:ABBV – Free Report) – Stock analysts at Zacks Research issued their Q2 2024 EPS estimates for AbbVie in a note issued to investors on Tuesday, July 23rd. Zacks Research analyst ...
AbbVie (ABBV) Set to Announce Earnings on Thursday
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) will be posting its quarterly earnings results before the market opens on Thursday, July 25th. Analysts expect AbbVie to post earnings of $3.06 per share ...
Mirae Asset Global Investments Co. Ltd. Purchases New Position in Arcutis Biotherapeutics, Inc....
ETF DAILY NEWS· 7 days agoMirae Asset Global Investments Co. Ltd. purchased a new stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) in the 1st quarter, according to its most recent filing with the SEC ...
Protagonist Therapeutics (NASDAQ:PTGX) Price Target Increased to $51.00 by Analysts at BTIG Research
ETF DAILY NEWS· 2 days agoProtagonist Therapeutics (NASDAQ:PTGX – Free Report) had its target price boosted by BTIG Research from $41.00 to $51.00 in a research note released on Wednesday morning, Benzinga reports. HC ...
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Shares Sold by Allspring Global Investments Holdings...
ETF DAILY NEWS· 4 days agoAllspring Global Investments Holdings LLC lessened its stake in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 22.2% during the first quarter, according to the company ...
